Viking Therapeutics, Inc. - Common Stock (VKTX)
CUSIP: 92686J106
Q1 2018 13F Holders as of 31 Mar 2018
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 113,177,462
- Total 13F shares
- 20,905,622
- Share change
- +11,566,606
- Total reported value
- $91,354,000
- Put/Call ratio
- 18%
- Price per share
- $4.37
- Number of holders
- 62
- Value change
- +$50,569,356
- Number of buys
- 49
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92686J106:
Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1.9%
|
2,145,300
|
$8,710,000 | — | 31 Dec 2017 | |
| Sio Capital Management, LLC |
13F
|
Company |
1.1%
|
1,250,250
|
$5,076,000 | — | 31 Dec 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.87%
|
985,752
|
$4,002,000 | — | 31 Dec 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.8%
|
903,300
|
$3,667,000 | — | 31 Dec 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.62%
|
702,972
|
$2,854,000 | — | 31 Dec 2017 | |
| Park West Asset Management LLC |
13F
|
Company |
0.53%
|
600,000
|
$2,436,000 | — | 31 Dec 2017 | |
| Opaleye Management Inc. |
13F
|
Company |
0.42%
|
480,558
|
$1,951,000 | — | 31 Dec 2017 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.38%
|
433,900
|
$1,762,000 | — | 31 Dec 2017 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.33%
|
378,520
|
$1,537,000 | — | 31 Dec 2017 | |
| Global IMC LLC |
13F
|
Company |
0.22%
|
246,520
|
$1,001,000 | — | 31 Dec 2017 | |
| David M. Knott |
13F
|
Individual |
0.2%
|
232,000
|
$942,000 | — | 31 Dec 2017 | |
| Iguana Healthcare Management, LLC |
13F
|
Company |
0.2%
|
225,000
|
$913,000 | — | 31 Dec 2017 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.17%
|
194,930
|
$791,000 | — | 31 Dec 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
117,619
|
$477,000 | — | 31 Dec 2017 | |
| Cornerstone Capital, Inc. |
13F
|
Company |
0.08%
|
86,650
|
$352,000 | — | 31 Dec 2017 | |
| Creative Planning |
13F
|
Company |
0.06%
|
70,000
|
$284,000 | — | 31 Dec 2017 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.06%
|
70,000
|
$284,000 | — | 31 Dec 2017 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
53,158
|
$216,000 | — | 31 Dec 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
40,052
|
$163,000 | — | 31 Dec 2017 | |
| Alpine Global Management, LLC |
13F
|
Company |
0.04%
|
40,000
|
$162,000 | — | 31 Dec 2017 | |
| FNY Partners Fund LP |
13F
|
Company |
0.01%
|
15,000
|
$60,000 | — | 31 Dec 2017 | |
| IHT Wealth Management, LLC |
13F
|
Company |
0.01%
|
11,725
|
$60,000 | — | 31 Dec 2017 | |
| SHEPHERD KAPLAN KROCHUK, LLC |
13F
|
Company |
0.01%
|
13,570
|
$55,000 | — | 31 Dec 2017 | |
| Iron Gate Global Advisors LLC |
13F
|
Company |
0.01%
|
10,778
|
$44,000 | — | 31 Dec 2017 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
10,000
|
$41,000 | — | 31 Dec 2017 | |
| Parallax Volatility Advisers, L.P. |
13F
|
Company |
0.01%
|
7,474
|
$30,000 | — | 31 Dec 2017 | |
| FIFTH THIRD BANCORP |
13F
|
Company |
0%
|
5,250
|
$21,000 | — | 31 Dec 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
3,000
|
$12,000 | — | 31 Dec 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
2,300
|
$9,000 | — | 31 Dec 2017 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0%
|
2,100
|
$9,000 | — | 31 Dec 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
1,685
|
$7,000 | — | 31 Dec 2017 | |
| REILLY FINANCIAL ADVISORS, LLC |
13F
|
Company |
0%
|
1,250
|
$5,000 | — | 31 Dec 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
703
|
$3,000 | — | 31 Dec 2017 |
Institutional Holders of Viking Therapeutics, Inc. - Common Stock (VKTX) as of Q1 2018
As of 31 Mar 2018,
Viking Therapeutics, Inc. - Common Stock (VKTX) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,905,622 shares.
The largest 10 holders included
Boxer Capital, LLC, RA CAPITAL MANAGEMENT, LLC, ArrowMark Colorado Holdings LLC, SPHERA FUNDS MANAGEMENT LTD., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Sio Capital Management, LLC, Opaleye Management Inc., RENAISSANCE TECHNOLOGIES LLC, and Polar Capital LLP.
This page lists
62
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q4 2017 Across Filers
Q4 2017 holders
32
Q1 2018 holders
62
Holder diff
30
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.